Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …

Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Anti-inflammatory drugs such as corticosteroids may beneficially modulate the host
inflammatory response to coronavirus disease 2019 (COVID-19) pneumonia. The aim of this …

Objective To assess the effectiveness of corticosteroids on outcomes of patients with
coronavirus disease 2019 (COVID-19) pneumonia requiring oxygen without mechanical …

Background Inhaled corticosteroids are well established for the long‐term treatment of
inflammatory respiratory diseases such as asthma or chronic obstructive pulmonary disease …

The most beneficial effect of corticosteroid therapy in COVID‐19 patients has been shown in
subjects receiving invasive mechanical ventilation (IMV), corresponding to a score of 6 on …

Importance Severe pulmonary infections, including COVID-19, community-acquired
pneumonia, influenza, andPneumocystispneumonia, are a leading cause of death among …

Background: The impact of inhaled corticosteroid (ICS) in the interaction between asthma,
COVID-19 and COVID-19 associated outcomes remain largely unknown. The objective of …

Objective: To review available evidence on corticosteroids in acute respiratory distress
syndrome (ARDS), Coronavirus Disease 2019 (COVID-19), and other viral pneumonias …

BACKGROUND Corticosteroids are widely used in patients with COVID 19, although their
benefit-to-risk ratio remains controversial. METHODS Patients with severe COVID-19 …